Our aims in this study are to evaluate the expression of ER and PR and the overexpression of Her-2/neu in patients with breast cancer in Jordan, and to compare the expression of these with other prognostic parameters for mammary carcinomas, such as histological type, histological grade, tumor size, patients' age and number of lymph node metastases. This evidence concerns the gene PGR and breast carcinoma.